Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/26/1996 | CA2215122A1 Il-13 receptor specific chimeric proteins and uses thereof |
09/26/1996 | CA2215104A1 Compounds and methods for the detection of t. cruzi infection |
09/26/1996 | CA2214591A1 Aspergillus arabinofuranosidase |
09/26/1996 | CA2214107A1 Fucopeptides |
09/26/1996 | CA2211448A1 Rage tumor rejection antigens |
09/26/1996 | CA2211191A1 Nonpeptides as tachykinin antagonists |
09/26/1996 | CA2190510A1 Corneal angiogenesis inhibitor |
09/25/1996 | EP0733706A2 Apoptosis-regulating proteins |
09/25/1996 | EP0733702A1 Stable transglutaminase preparations and process for their preparation |
09/25/1996 | EP0733645A1 Novel synthetic peptide, lung surfactant containing the same, and remedy for respiratory distress syndrome |
09/25/1996 | EP0733644A1 Glucagon-like insulinotropic complexes, compositions and methods |
09/25/1996 | EP0733642A1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions |
09/25/1996 | EP0733640A1 Double-stranded oligonucleotide and carcinostatic agent containing the same as active ingredient |
09/25/1996 | EP0733620A1 Alpha-substituted-1-benzyl-naphthyls |
09/25/1996 | EP0733378A2 Preparation of autologous plasma and fibrin gel |
09/25/1996 | EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells |
09/25/1996 | EP0733371A1 Agent for the subcutaneous application of protein C |
09/25/1996 | EP0733370A1 Antagonistic inhibitor against mesenchymal cell growth |
09/25/1996 | EP0733369A1 Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors |
09/25/1996 | EP0733213A1 Process for the production of combinatorial compound libraries |
09/25/1996 | EP0733122A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein |
09/25/1996 | EP0733118A1 Mammal with enhanced liver expression of a transgene |
09/25/1996 | EP0733113A1 Influenza vaccine |
09/25/1996 | EP0733111A1 IFN-$g(g)RECEPTOR $g(b)-CHAIN AND DERIVATIVES THEREOF |
09/25/1996 | EP0733110A1 Tuberous sclerosis 2 gene and uses thereof |
09/25/1996 | EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
09/25/1996 | EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
09/25/1996 | EP0733106A1 Plant arabinogalactan protein (agp) genes |
09/25/1996 | EP0733104A1 Purification of vitamin-k dependent proteins by membrane chromatography |
09/25/1996 | EP0733103A1 Generation of high titers of recombinant aav vectors |
09/25/1996 | EP0733101A1 Glucose responsive insulin secreting beta-cell lines and method for producing same |
09/25/1996 | EP0733072A1 Antibody against carcinoembryonic antigen (cea) |
09/25/1996 | EP0733071A1 Antagonists to chaperonin 10 |
09/25/1996 | EP0733069A1 Purified primate ctla-8 antigens and related reagents |
09/25/1996 | EP0733068A1 METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF $i(NEU) MEDIATED TRANSFORMATION |
09/25/1996 | EP0733067A1 N-terminally chemically modified protein compositions and methods |
09/25/1996 | EP0733066A1 Pretargeting methods and compounds |
09/25/1996 | EP0733065A1 Novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases |
09/25/1996 | EP0733064A1 NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, $i(DER P) III, AND USES THEREFOR |
09/25/1996 | EP0733061A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
09/25/1996 | EP0733060A1 Metal chelators |
09/25/1996 | EP0733057A1 Origin of replication complex genes, proteins and methods |
09/25/1996 | EP0732944A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
09/25/1996 | EP0732943A1 Three-step pretargeting methods and compounds |
09/25/1996 | EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
09/25/1996 | EP0732939A1 Preparation and use of immunoconjugates |
09/25/1996 | EP0732938A1 Method of treating intestinal disorders |
09/25/1996 | EP0732935A1 Lyophilized stem cell factor formulations |
09/25/1996 | EP0732934A1 Long-acting injection suspensions and a process for their preparation |
09/25/1996 | EP0732933A1 Method of treating renal disease by administering igf-i and igfbp-3 |
09/25/1996 | EP0732932A1 Use of urinastatin-like compounds to prevent premature delivery |
09/25/1996 | EP0732929A1 Therapeutic use of cis-element decoys in vivo |
09/25/1996 | EP0732915A1 Local delivery of fibrinolysis enhancing agents |
09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
09/25/1996 | EP0674513B1 Retroviral protease inhibiting compounds |
09/25/1996 | EP0669832B1 Method for treatment or prevention of obesity |
09/25/1996 | EP0587805B1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
09/25/1996 | EP0511308B1 Chimeric immunoglobulin for cd4 receptors |
09/25/1996 | EP0438566B1 Substance P antagonists |
09/25/1996 | EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
09/25/1996 | CN1131952A Single-chain forms of glycoprotein hormone quartet |
09/25/1996 | CN1131950A Recombinant C140 receptor and its agonists and antagonists |
09/25/1996 | CN1131674A Glucagon insulinotropic complexes, compositions and methods |
09/25/1996 | CN1131539A Treatment of disease and conditions associated with macrophage infiltration |
09/24/1996 | USRE35338 Sustained release delivery of water soluble bio-molecules and drugs using phosphokipid-coated microcrystals, microdroplets and high-concentration lipsomes |
09/24/1996 | US5559213 Polyethylene-protein conjugates |
09/24/1996 | US5559212 Frog embryo and egg-derived tumor cell anti-proliferation protein |
09/24/1996 | US5559211 Biologically active product produced by streptococcus pyogenes and method of purification |
09/24/1996 | US5559209 Regulator regions of G proteins |
09/24/1996 | US5559208 Anti-obesity proteins |
09/24/1996 | US5559099 Penton base protein and methods of using same |
09/24/1996 | US5559097 Use of a pregnancy specific protein as an immunosuppressive |
09/24/1996 | US5559096 Pharmaceutical compositions against gastric disorders |
09/24/1996 | US5559095 Delayed treatment method of reducing ischemia-related neuronal damage |
09/24/1996 | US5559094 AspB1 insulin analogs |
09/24/1996 | US5559093 N-terminally truncated hst-1 is a platelet-increasing factor |
09/24/1996 | US5559034 Synergistic antifungal protein and compositions containing same |
09/24/1996 | US5559028 Methods of enhancing or antigen presentation to T cells inhibiting |
09/24/1996 | US5559025 Expression of mature proteinase 2A, the partial purification thereof and preparation of substrates having an inhibitory effect |
09/24/1996 | US5559023 Tumor suppressor gene |
09/24/1996 | US5559021 DNA encoding a novel mammalian transporter homologous to neurotransmitter transporters and uses thereof |
09/24/1996 | US5559012 Monoclonal antibodies detected with cytokines and kits |
09/24/1996 | US5559009 Voltage-gated potassium channel gene, KV1.7, vectors and host cells comprising the same, and recombinant methods of making potassium channel proteins |
09/24/1996 | US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof |
09/24/1996 | US5558869 Major peanut allergen ara h II |
09/24/1996 | US5558865 Nmo1 monoclonal antibody |
09/24/1996 | US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies |
09/24/1996 | US5558863 Method for treatment of herpes virus infections |
09/24/1996 | US5558860 Viral vaccines |
09/24/1996 | US5558852 Methods of treating melanomas and gliomas with monoclonal antibody Me1-14 |
09/24/1996 | US5558085 Intrapulmonary delivery of peptide drugs |
09/24/1996 | CA2172436A1 Compositions and methods for increasing the immunogenicity of tumor cells |
09/24/1996 | CA2026418C Polypeptides useful as blockers of calcium channels |
09/24/1996 | CA1338604C Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof |
09/22/1996 | CA2172325A1 Apoptosis-regulating proteins |
09/22/1996 | CA2172217A1 Agent for subcutaneous administration of protein c |
09/22/1996 | CA2150080A1 Glucagon-like insulinotropic complexes, compositions and methods |
09/19/1996 | WO1996028568A1 Cd40 binding compositions and methods of using same |
09/19/1996 | WO1996028564A1 Novel recombinant dna vectors for gene therapy |
09/19/1996 | WO1996028563A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |